Ads by Google:


Categories

No categories found.


No popular authors found.
No popular articles found.
(Page 3 of 16)   « Prev  1  2  
3
  4  5  Next »

The North American Society for the Study of Celiac Disease (NASSCD) today announced a call for all restaurants and food manufacturers to properly label gluten-free products to avoid confusion that has the potential to threaten the health of people with celiac disease. (View the statement NASSCD also issued this week at http://www.nasscd.org/wp-content/uploads/2012/05/NASSCD-Statement-on-Dominos-Pizza.pdf .)

The move comes after two restaurant chains, Chuck E. Cheese and Domino's Pizza, last week separately announced new gluten-free food product offerings that provide significantly different levels of safety for people with celiac disease.

Celiac disease is a genetically inherited autoimmune condition that can damage the small intestine, and can lead -- if untreated -- to further serious complications, including anemia, osteoporosis, infertility and even certain cancers. Celiac disease is triggered by the consumption of gluten, a protein found in wheat, rye and barley.

"We want to eliminate the market confusion that has surfaced recently, provide clarifying facts and information about gluten-free labeling to food manufacturers, and ensure the public's safety," said Stefano Guandalini, M.D., president of the NASSCD, and founder and medical director of the University of Chicago Celiac Disease Center. "Additionally, there is too much variance from manufacturer to manufacturer."

The announcements of new gluten-free pizza offerings by Chuck E. Cheese and Domino's Pizza are a case in point.

In its May 11, 2012, press release, Chuck E. Cheese described a process intended to protect customers from inadvertent gluten exposure: "To avoid cross contamination or accidental exposure to gluten ingredients in Chuck E. Cheese's kitchens, the personal cheese pizza, manufactured by USDA/FDA-approved, gluten-free facility Conte's Pasta, will arrive to stores in frozen, pre-sealed packaging. The bake-in-bag pizza will remain sealed while cooked and delivered and until opened and served with a personal pizza cutter at families' tables by the adult in charge."

On the other hand, in a May 7, 2012, press release, Domino's Pizza announced a gluten-free pizza crust that it said was "appropriate for those with mild gluten sensitivity" but not for people with celiac disease because "Domino's cannot guarantee that each handcrafted pizza will be completely free from gluten."

"Our position at the NASSCD is that a product is either gluten free or it is not," Guandalini said. "There is no in between. In fact, gluten exposure -- including in minute amounts from cross-contamination -- can be detrimental to people with celiac disease. Repeated exposure can lead to potentially grave medical complications, not to mention a poor quality of life."

According to Guandalini, as little as 10 mg of gluten in a day can reactivate -- in very sensitive patients -- celiac disease.

"We strongly encourage Domino's and other restaurants and food manufacturers to properly label and market gluten-free offerings, as so many responsible companies have done" Guandalini said. "There should be no need for disclaimers. A product is gluten free, or it is not. Marketing a product to be "sort-of" gluten free or "low" gluten is completely useless for those who require the strict diet."

The NASSCD, along with other organizations, has been working with the U.S. Food & Drug Administration to put forth a "gluten-free" standard. That standard would require that, in order to claim a food product as "gluten free," the end product must contain less than 20 parts per million (ppm) of gluten (equivalent to less than 20 mg in about 2.2 lbs.). Anything short of this standard would be considered false advertising.

The NASSCD was founded last year to advance the fields of celiac disease and gluten-related disorders by fostering research, and by promoting excellence in clinical care, including diagnosis and treatment of patients with these conditions. Approximately 1 percent of the population is estimated to suffer from celiac disease, though the condition often is undiagnosed or misdiagnosed. Non-celiac gluten sensitivity is a less well-understood condition with a broad range of symptoms, including fatigue, migraine headaches and digestive disorders, and whose mechanism or cause is not yet identified, and that presently cannot be diagnosed by any medical test. Visit the NASSCD at www.nasscd.org .

Stefano Guandalini, M.D., is president of the NASSCD, and founder and medical director of the University of Chicago Celiac Disease Center. He is also a professor of pediatrics, and serves as chief of the Section of Gastroenterology at the University of Chicago Comer Children's Hospital. Contact Dr. Guandalini at: sguandalini@peds.bsd.uchicago.edu.

SOURCE: The North American Society for the Study of Celiac Disease

Krispak, Inc. of Grand Rapids, MI is voluntarily recalling 16 cases of GFS® Hostess Candy Mix 8-48 oz packages due to a potential mis-pack, resulting in undeclared allergens. A small number of cases of GFS® Hostess Candy Mix were inadvertently put into GFS® Chocolate Sprinkles packages. GFS® Hostess Candy Mix contains wheat and milk and may contain egg, none of which are declared on the GFS® Chocolate Sprinkles package. People who have an allergy or severe sensitivity to milk, eggs, and wheat run the risk of serious or life-threatening allergic reaction if they consume these products.

The GFS® Hostess Candy Mix in question was distributed from April 5th – 19th to Indiana, Ohio, Michigan, Kentucky, Pennsylvania, and Tennessee Gordon Food Service Marketplace Stores.

Product is in a red stand up GFS®, 48 oz pouch that says Chocolate Sprinkles. The code date is embossed on the top of the pouch as 088 12.

No illnesses have been reported to date.

Subsequent investigation indicates the problem was caused by a temporary breakdown in the company's production and packaging processes.

Consumers who have purchased GFS® Hostess Mix by the case, or GFS® Chocolate Sprinkles should investigate their purchase. Consumers whom received mis-packed product are urged to return it to the place of purchase for a full refund. Consumers with questions may contact Krispak, Inc. at 1-616-554-1377 during the hours of 06:00 – 14:00 ET.

Source:

MEDITERRA S.A. of Chios Greece is recalling PIE WITH CHIOS MASTIHA 80g, HONEY PIE WITH ALMONDS 80g, HALVA PIE WITH CHIOS MASTIHA AND PEANUTS 80g, FIGS STUFFED WITH ALMONDS 360g , GREEK GARLIC SPREAD WITH ALMONDS 180g, HANDMADE TRAHANA PASTA WITH MASTIHA 340g, SMOKED EGGPLANT SPREAD WITH CHIOS MASTIHA 180g, and SPICY GARLIC SPREAD WITH CHIOS MASTIHA 180g, because they may contain undeclared allergens.

Specifically mastiha pie, honey pie and halva pie contain egg albumin, wheat flour and nuts (almonds). The handmade Τraxana contains milk yogurt and wheat gluten. The figs contain nuts (almonds). The Greek garlic spread contains nuts (almonds) and wheat bread. The smoked eggplant contains nuts (pine nuts). The spicy garlic spread with mastiha contains wheat bread. People who have allergies to egg, milk, wheat, and/or nuts run the risk of serious or life-threatening allergic reaction if they consume these products.

These products have been sold in the United States via internet sales through www.mastihashopny.com  and from one retail store located at 145 Orchard St., New York, New York.

The mastiha pie, halva pie and honey pie are packaged in a plastic bag and wrapped in paper as secondary packaging. Mastiha pie is marked with LOT09120202 and best before end 12/30/2012. Honey pie is marked with LOT27111107 and best before end 06/30/2012. Halva pie is marked with LOT85111104 and best before end 06/25/2012.

The figs with almonds and handmade trahana are packaged in a plastic vacuum bag and a paper box as secondary packaging. Figs are marked with LOT16111115 and best before end 04/30/2012. The handmade trahana pasta is marked with LOT03101125 and best before end 04/30/2012.

The Greek garlic spread, smoked eggplant spread, and spicy garlic spread are packaged in a glass jar with a black lid. Greek garlic spread is marked with LOT03110916 and best before end 09/30/2012. Smoked eggplant is marked with LOT3111020 and best before end 04/30/2013. Spicy garlic spread is marked with LOT01110916 and best before end 09/30/2012.

No illnesses have been reported to date in connection with this problem.

The recall was initiated after it was discovered that the allergen-containing products were distributed in packaging that did not reveal the presence of the allergens. Specifically we did not declare that albumin is egg albumin, yogurt is milk yogurt, white bread is wheat bread, as well as almonds and pine nuts are nuts.

MEDITERRA S.A. has printed and sent corrected labels for these products on 04/05/2012 and all products now properly declare all ingredients, including any allergens.

Consumers who have purchased any of these products are urged to return them to the place of purchase for a full refund. Consumers with questions may contact the U.S. retail store at 212-253-0895 between 12:00pm and 7:00pm Eastern Time, Tuesday through Sunday or the manufacturer directly at 0030-22710-51805.

Consumers may visit our website at www.mastihashop.com  for more information about Mediterra S.A.

Source:
Where do you want to eat? This is a very common question that we all are asked everyday but to those of us who suffer from "Celiac" its frustrating and complicated. I always end up having to explain my new life without gluten, and I will admit that it becomes tiresome but its another side effect of the disease. I have done research on where and what I can eat when we go out to dinner with family or friends. A lot of places do offer gluten free menu options, even some fast food chains but from my experience we have to be cautious of cross contamination. Regardless of how many questions I ask about the ingredients, sauces, how it's cooked or what else is cooked on that grill I still seem to get cross contamination a lot. I tend not to eat out or i will eat before I leave the house. So no breakfast on the way to work and no fast food lunches during work for me. I take the time and prepare my meals so I can ensure that all the ingredients are safe, but it's time consuming. My daily diet consists of whole foods, fresh meats and fish. I stay away from frozen foods and vegetables, due to the processing which gluten is often used. I also pay attention to the notes about what else is processed in that plant. "Where do you want to eat Rich?"....At home.
Jelly Belly Candy Co. of Fairfield, CA is recalling Peter Rabbit Deluxe Easter Mix “Gluten Free” candies, because the malted milk balls in the mix contain wheat.
 
The recall only affects 2.7 oz. bags with UPC 071567992794, which have lot codes 111111, 111215, and 120120. They are marked with “best before” dates of January 11, 2013, February 15, 2013, and March 20, 2013 respectively.
 
Gluten is a protein found in grains such as wheat, barley, rye, and triticale. A gluten-free diet is a treatment from celiac disease, a condition in which the digestion of gluten causes damage to the inner surface of the small intestine and an inability to absorb certain nutrients.
 
“Undeclared allergens were the leading cause of FDA food recalls in 2011, but food allergen testing can prevent costly market withdrawals,” states Joy Dell’Aringa, M.S., RM (NRM), CFSP, National Food Microbiology Supervisor at EMSL Analytical, one of the nation’s leading commercial testing laboratories. “EMSL offers extensive food allergen testing, including gluten, total milk, soy, peanut, egg, almond, crustacean, and many others.”

Source:
Han Yang Inc., a Milwaukee, Wisc., establishment, is recalling approximately 25,600 pounds of cooked pork hocks because of misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced today. The products contain wheat, a known allergen, which is not noted on the label.

The products subject to recall include: [View Label]:
Shrink wrapped packages of various weights of "JANG CHUNG DONG HAN YANG KING JOAK BAL COOKED PORK HOCKS."

The products bear the establishment number "EST. 21880" inside the USDA mark of inspection, and have a four month shelf life. The products subject to recall were produced between Oct. 7, 2011, and Feb. 7, 2012, and were distributed for wholesale and retail use in Los Angeles, Calif. and Chicago, Ill. areas.

The problem was discovered by an FSIS inspector during a label review. The inspector reviewed the ingredient statement of a seasoning component used in the product and the finished product label and discovered that wheat, an allergen, was listed as an ingredient in the component, but not declared on the finished product label. FSIS and the company have received no reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers.

Consumers and media with questions about the recall should contact the company's President, Chang Choi, at (414) 389-1099.

My Blessing

I have a new appreciation for the fact that my diet has had to be modified. Without the need to analyze what I am eating, the revelation and reality of what I am eating would not have occurred. I was a person always conscious of healthy eating habits, so I thought. Delving into the world of food has been a very frightening and eye opening experience. Being forced to read labels has taught me to be more cautious and buy from the fresh and organic sections of the market. We are inundated with chemicals, genetically modified products and fillers. The more I learn about those ingredients the more I believe, my dietary limitations are a blessing, not a tragedy.
Price Chopper Supermarkets is issuing a voluntary recall on 'Gourmet Stuffed Clams' from its seafood departments with a scale code of 209181. This product is being recalled due to the fact that it contains milk, wheat and eggs, three known allergens, which are not listed on the store generated ingredient label.

The stuffed clams were sold chain wide in Price Chopper seafood departments between September 30 and December 30. The label was updated on December 30 to correctly reflect all of the ingredients contained in the product.

In addition to alerting the media, Price Chopper has initiated its Smart Reply notification program, which uses purchase data and consumer phone numbers on file in connection with the company's AdvantEdge (loyalty) card to alert those households that may have purchased the product in question.

Customers can return the product to their local Price Chopper for a full refund. For more information, visit the pricechopper.com  website or call Price Chopper at 1-800-666-7667, option 3 between the hours of 8:30am and 7:00pm.
Source:
Blount Fine Foods of Fall River, MA is recalling a single date code of Blount Fine Foods branded Rip Roarin’ Crab Soup in 16 ounce retail cup pack size because of undeclared milk, wheat and crab allergens. People who have an allergy or severe sensitivity to milk, wheat or crab run the risk of suffering serious or life-threatening reactions if they consume this product.

Product:
Blount Fine Foods branded Rip Roarin’ Crab Soup 16oz retail cup
Product Code: 71116             Lot Number: 1202117D              Use or Freeze By: 2/10/2012

The Rip Roarin’ Crab Soup back label incorrectly identifies the product as Manhattan Clam Chowder and the ingredient statement does not declare the allergens-milk, wheat or crab.

The lot code and sell by date are printed in black ink on the bottom of the cup.

No other products or date codes are affected by this recall.

The product was distributed to select Whole Foods Retail stores on the Eastern Coast of the United States

No illnesses have been reported to date.

Consumers who have purchased item listed above with affected lot number are urged to return it to the place of purchase for a full refund. Consumers who have health-related concerns should contact their physician. Consumers with questions may contact the Blount Fine Foods at 1-800-274-2526, Monday – Friday, 8 a.m.-5 p.m. Eastern Time. Additional information is available at www.blountfinefoods.com.

Source:
Enhorabuena!, Bayamón, PR is issuing this alert due to undeclared milk, wheat, tree nuts, and eggs in the product “Palitos de Guayaba” (Guava Sticks) . People who have allergies to milk, wheat, tree nuts and eggs run the risk of serious or life-threatening allergic reactions if they consume the products.

The product was distributed in PR retail stores during December 2011. The product is packaged in 7 oz bags, 11 oz cans and 10 units packs.

No illnesses have been reported to date in connection with this problem.

As a corrective action, the product is being re-labeled with new ingredient listings and citing allergens.

Consumers with any question may contact the company at 787-797-3918 or at info@enhorabuenainc.com
Source:
Shamrock Foods, a Phoenix, Ariz., establishment, is recalling approximately 7,500 pounds of marinated beef and marinated chicken products because the marinated beef product contains soybeans, wheat, and sulfites, and the marinated chicken product contains wheat, milk and sulfites, known allergens that are not declared on the label for either product.

The products subject to recall include:
  • Cases containing 2 10-lb. packages per case of “CHICKEN, BREAST DOUBLE LOBE MARINATED RANDOMS.” These products have an identifying item number of “2844671.”
  • Cases containing 2 10-lb packages per case of “BEEF CHUCK, SHOULDER CLOD 1/2” SLICED MARINATED USDA PRIME.” These products have an identifying item number of “3096311.”
The recalled products were produced from Dec. 1, 2011 through Dec. 29, 2011, and shipped to food service institutions in Arizona.

The problem was discovered by FSIS during a routine inspection. FSIS and the company have received no reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers.

Consumers and members of the media with questions about the recall should contact Sandy Kelly, Senior Director of Marketing and Communications, Shamrock Foods, at (602) 477-2401 or via e-mail at Sandy_Kelly@shamrockfoods.com.

Source:
Sirocco Enterprises, Inc, Jefferson, LA is recalling its 33.8 fluid ounce (1 Liter) bottles of Pat O’Brien’s Bloody Mary Cocktail Mix because it contains undeclared soy and wheat. People who have allergies to soy and wheat run the risk of serious or life-threatening allergic reaction if they consume these products.

Bottles of the recalled Pat O’Brien’s Bloody Mary Cocktail Mix were distributed nationally in retail stores and through internet purveyors.

No illnesses have been reported to date in connection with this problem.

The recall was initiated after it was discovered that the Pat O’Brien’s Bloody Mary Cocktail Mix was distributed in packaging that did not reveal the presence of soy and wheat. Subsequent investigation indicates the problem was caused by a change in an ingredient.

Production and distribution of the product has been suspended until FDA and the company are certain that the problem has been corrected.

Consumers who have purchased 33.8 fluid ounce (1 Liter) bottles of Pat O’Brien’s Bloody Mary Cocktail Mix are urged to return them to the place of purchase for a full refund. Consumers with any questions may contact the company at 1-504-834-1549 during the hours of 8:30 AM - 4:30 PM, CST.

Source:

Popcorn Palace of Schiller Park, IL, is issuing this statement to alert people with allergies to Peanuts, Tree Nuts, Milk, Soy, and Wheat that some of our 1-Gallon Value Bags contain the undeclared ingredients.  Bags were shipped with the ingredient and allergen information not applied directly to the immediate container and important allergen information may not have reached the end consumer.

People with one of these allergies run a risk of serious or potential life threatening allergic reactions if they consume these products:
  • Cheddar Cheese, 1-Gallon Value Bag (contains milk, soy)
  • White Cheddar, 1-Gallon Value Bag (contains milk, soy)
  • Chicago Style, 1-Gallon Value Bag (contains milk, soy)
  • Gourmet Caramel, 1-Gallon Value Bag (contains milk, soy)
  • Rainbow, 1-Gallon Value Bag (contains soy)
  • Caramel Nut, 1-Gallon Value Bag (contains milk, soy, peanuts, tree nuts (almonds, cashews))
  • Chocolate Drizzle Caramel, 1-Gallon Value Bag (contains milk, soy)
  • Macadamia Butter Crunch, 1-Gallon Value Bag (contains milk, soy, macadamia nuts)
  • Cookies & Cream, 1-Gallon Value Bag (contains milk, soy, wheat)
  • Spicy Cheese, 1-Gallon Value Bag (contains milk, soy, wheat)
  • No illnesses have been reported in connection with these products.
These products are completely safe for anyone without allergies to consume.

Affected products would have been purchased after October 1st, 2011 through one of our fundraising programs.

This notice was initiated after it was discovered that shipments did not include the ingredient and allergen information.  This issue has been corrected with updated packaging that includes nutrition facts, ingredients, and allergens applied directly to every item.

Consumers who have questions or would like additional information can call 1-800-873-2676.

Source:
Velvet Creme Popcorn Co. of Westwood, Kansas, is issuing this statement to alert people with allergies to Milk, Soy and Wheat that several of our products contain the undeclared ingredients. These people run a risk of serious or potential life threatening allergic reaction if they consume the following products:
  • Velvet Crème Peanut Brittle,  4 oz. cellophane bags (contains milk)
  • Velvet Crème Tail Gate Crunch,  1 lb. and 8 oz. cellophane bags (contains soy and wheat)
  • Velvet Crème Sweet Cajun Heat, 1 lb. and 8 oz. cellophane bags (contains soy and wheat)
These products do not have any lot codes.   Affected products would have been purchased before December 13, 2011, in our retail store in Westwood, Kansas.
 
These products are completely safe for anyone without allergies to consume.

No illnesses have been reported in connection with these products.

The recall was initiated after it was discovered the products had undeclared ingredients of milk, soy and wheat.  Subsequent investigation indicates the problem was caused by a temporary breakdown in the company’s production and packaging process and has now been corrected.

Consumers who would like to return the products can do so at the retail store in Westwood, Kansas, Monday thru Saturday 9:00 am to 5:30 pm. Consumers with questions may contact the company at 1-888-553-6708 during the hours of 9:00 am and 5:30 pm.

Source:
ImmusanT, Inc. announced today it has raised $20 million in Series A financing from Vatera Healthcare Partners LLC to advance development of the biotechnology company's immunotherapeutic vaccine Nexvax2®, companion diagnostic and monitoring tool for celiac disease. The proceeds will fund the Nexvax2 therapeutic and diagnostic development plan to the point of demonstrating proof-of-concept. ImmusanT expects to initiate the next clinical trial in early 2012.

"ImmusanT's Nexvax2 and companion diagnostic address the rapidly growing number of patients diagnosed with celiac disease whose only option is a strict diet that eliminates gluten. At Vatera we seek to invest in therapies that fulfill unmet medical needs and offer a significant clinical benefit to patients. We believe that ImmusanT's technology has the potential to dramatically improve the quality of life for celiac disease patients," said Sundar Kodiyalam, Managing Director of Vatera Holdings LLC.

ImmusanT's product pipeline includes Nexvax2, which combines three proprietary peptides that elicit an immune response in patients with celiac disease who carry the immune recognition gene HLA-DQ2, which includes approximately 80% of patients. ImmusanT Scientific Founder and Chief Scientific Officer Dr. Bob Anderson discovered the three peptides responsible for making gluten toxic to people with the disease. Nexvax2 is designed to tolerize celiac disease patients to the toxic effects of gluten, enabling them to return to a normal diet. Safety, tolerability and bioactivity of Nexvax2 have been established in a Phase 1 clinical study and presented at this year's Digestive Disease Week.

ImmusanT is also developing a proprietary whole-blood functional T-cell test for use both as a standalone diagnostic for celiac disease and as a monitoring tool for the therapeutic. In the company's dual-track product development strategy, clinical trial subjects will be screened using the diagnostic along with standard serology tests to identify patients most likely to respond to Nexvax2.

"There is tremendous enthusiasm for Nexvax2 from celiac patients and clinicians who want a therapy that allows patients to resume a normal diet and return to good health and improved quality of life. The financial backing and support of Vatera Healthcare Partners will allow us to round out our team and advance our research and development programs to bear out this hypothesis," said Leslie J. Williams, Founder, President and CEO of ImmusanT, Inc.

About Celiac Disease and Nexvax2
Celiac disease is an inherited autoimmune disorder that is triggered by foods containing gluten, the main protein in wheat, rye and barley, affecting the digestive process of the small intestine.  Nexvax2 is delivered intradermally in small doses to reprogram and tolerize the disease-causing T-cells triggered by the patient's immune response to gluten. The approach is similar to treatments for allergies to cats, ragweed or dust mites, whereby repeated doses establish non-responsiveness to a specific antigen, and in the case of celiac disease, reduces or eliminates the body's rejection of dietary gluten. With no available drug therapy, the only option for the 1% of the global population that has celiac disease is a gluten-free diet, which is fraught with compliance issues and inadvertent exposure leaving patients at risk for long-term intestinal damage. By reprogramming the T-cell response, the Nexvax2 approach is designed to reduce inflammation in the villi that line the small intestine and are responsible for absorbing nutrients. This returns the intestine to a normal healthy state.

About Vatera Healthcare Partners LLC
Vatera Healthcare Partners LLC is a venture capital firm established by Michael Jaharis, Founder of Kos Pharmaceuticals, Inc., a specialty pharmaceutical company sold to Abbott Laboratories in 2006, and of Key Pharmaceuticals, Inc., a specialty pharmaceutical company that merged with Schering-Plough in 1986. Vatera focuses on investing in biopharmaceutical firms and products with the goal of building and growing companies by leveraging the team's collective experience and expertise in the pharmaceutical industry and strong network of relationships within industry and academia.

About ImmusanT, Inc.
ImmusanT is a privately-held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that improve diagnosis and treatment and return patients to a normal diet, good health and improved quality of life. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease, and a companion diagnostic and monitoring tool to improve celiac disease management. ImmusanT's targeted immunotherapy discovery platform can be applied to a variety of epitope-specific autoimmune diseases. More information can be found at www.ImmusanT.com.
Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today that the company was awarded U.S. Patent 8,071,101, "Antibody Therapy for Treatment of Diseases Associated With Gluten Intolerance."

This patent, which expires on May 27, 2029, provides broad coverage for treating celiac disease using orally administered antibodies produced by the Company's proprietary platform technology.  This newly issued patent includes claims covering the composition of matter for Avaxia's AVX-176 antibody, currently in development for celiac disease.

"We are pleased to receive this new patent," stated Barbara Fox, PhD, CEO of Avaxia Biologics.  "This is an important milestone for our company as it is our first issued patent and it validates that the company can obtain composition of matter claims for products derived from our antibody technology platform.  We are actively building a strong IP portfolio with additional patent applications that will cover the broad range of disease applications the company has created with its oral antibody technology."

Dr. Fox added, "This first patent covers AVX-176, an orally administered antibody designed to bind to gluten, the dietary protein that provokes celiac disease in susceptible patients.  We are currently conducting an NIH supported program to advance the development of AVX-176 into pre-clinical models of celiac disease.  Preliminary in vitro data are encouraging and we hope to be able to develop a product in the near future."
About celiac disease: Celiac disease is an inherited, autoimmune disease in which the lining of the small intestine is damaged from eating gluten and other proteins found in wheat, barley, rye, and possibly oats.  Celiac disease is also known as celiac sprue, nontropical sprue, and gluten-sensitive enteropathy.  The disease can develop at any point in life, from infancy to late adulthood.  The symptoms of celiac disease can vary significantly from person to person with the most common being abdominal bloating and pain, chronic diarrhea, vomiting, constipation and weight loss.  There is no medication available to treat the disease.  Patients must follow a lifelong gluten-free diet in an attempt to avoid symptoms.  More than 2 million people in the United States have the disease, or about 1 in 133 people.

About Avaxia Biologics, Inc.: Avaxia Biologics is a development-stage company developing oral antibody therapeutics that act locally within the gastrointestinal tract. The antibodies are designed to treat both diseases of the GI tract and metabolic diseases. Using its proprietary antibody platform, Avaxia is developing products for inflammatory bowel disease, GI acute radiation syndrome, celiac disease, oral mucositis, diabetes and obesity.
 
 Silva Sausage Co., a Gilroy, Calif. establishment, is recalling approximately 2,290 pounds of a chorizo sausage product because of misbranding and an undeclared allergen, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The product contains wheat, a known allergen, which is not noted on the label.

The products subject to recall include:
[View Label]:

5-lb. vacuum packs of “NETO’S MEXICAN CHORIZO 4/1.”

The product subject to recall bears the establishment number “6086” inside the USDA mark of inspection and can be further identified by the item number “18062” and lot codes “11279,” “11293,” “11304,” “11321,” “11333,” or “11341.” The product was produced between Oct. 1, 2011, and Dec. 9, 2011, and distributed for institutional use in Santa Clara, Calif.

FSIS discovered the problem during a label review at the establishment. The review revealed that cereal, which contained wheat, was used in the product and was inadvertently left off the product labels. FSIS and the company have received no reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers.

Consumers and media with questions about the recall should contact the company’s vice president, Rick Martins, at (408) 293-5437.

Consumers with food safety questions can "Ask Karen," the FSIS virtual representative available 24 hours a day at www.AskKaren.gov. The toll-free USDA Meat and Poultry Hotline 1-888-MPHotline (1-888-674-6854) is available in English and Spanish and can be reached from l0 a.m. to 4 p.m. (Eastern Time) Monday through Friday. Recorded food safety messages are available 24 hours a day.

Source:
Yes, it is the holiday season, and back online for 2011 are the Controllable Christmas Lights for Celiac Disease:
http://www.komar.org/cgi-bin/christmas_webcam

Once again, three live webcams and X10 technology allows web surfers to not only view the action, but also *control* 20,000+ lights ... plus inflate/deflate the giant 15' Santa Balloon, Santa on Skis, in a Helicopter, and flying a Plane ... along with Elmo, Frosty Family, SpongeBob SquarePants, and Homer Simpson Santa - D'OH!

Alek's Controllable Christmas Lights for Celiac Disease are onlThe website is totally free (and totally fun) and is one of my zany ways of raising awareness & soliciting donations for Celiac Disease - http://www.celiaccenter.org/news_xmas.asp - my two sons have this condition, so it's personal for me. If folks are so inclined, you can make an optional donation directly to the University of Maryland Center for Celiac Research. Over $60,000 has been raised with ... holiday lights - pretty wild.

While people around the world (146 countries last year) enjoy seeing the lights ON, environmentalists will be happy to know that they can turn the lights OFF with a click of the mouse. Better yet, this is the 7th year I'm using Wind Power and even though that is "clean" energy, I even did a Carbon Offset contribution for the half Ton of CO2 generated by the about one MegaWatt-Hour of power consumed - that's about the same as *one* cross-country airline trip. Finally, by providing online viewing via webcam, you don't need to burn fossil fuels by driving around to see Christmas lights ... Al Gore would be proud!

But HEY, the couple of bucks a day in electrical costs are well worth the joy it brings to people (especially the kids) when they see the display in person and/or on the web. There's even a Hi-Def option, so gather your family around the large screen and open up some Eggnog as the chestnuts are roasting on an open fire.


So surf on by, tell your friends, Blog/Facebook/Tweet about it and spread the word.
Merry Christmas and HO-HO-HO!
alek

P.S. In my last broadcast Email, I mentioned how my Cataract surgery had gone well and I've acquired a new "superpower." Since then, I got "tested" with a Monochromator at HP Labs which confirmed my ability to see Ultraviolet light. It's an interesting oddity and you can see some visual examples and read more at:
http://www.komar.org/faq/colorado-cataract-surgery-crystalens/ultra-violet-color-glow/
So while I could dress up as "Captain UV", it might be pretty scary to see me in purple cape and tights ...

PPS. I do "mail-all's" to my address book a few times a year, but if for any reason you'd rather not get these updates, please just let me know.
Silva Sausage Co., a Gilroy, Calif. establishment, is recalling approximately 1,010 pounds of British style banger sausages because of misbranding and an undeclared allergen, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced today. The products contain wheat, a known allergen, which is not noted on the label.

The products subject to recall include: [View Label (PDF Only)]
10-lb. cases of "Silva Sausage English Brand Bangers"

The products bear the establishment number "EST. 6086" inside the USDA mark of inspection. The cases can further be identified by the item number "10362" and lot codes "112271," "112911," or "112980." The products were distributed for institutional use in Livermore and Sacramento, Calif.

FSIS discovered the problem during a label review at the establishment, and it is believed that wheat was left off of the label when the company changed its in-house label printing program. FSIS and the company have received no reports of adverse reactions due to consumption of these products. Anyone concerned about a reaction should contact a healthcare provider.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers.

Consumers and media with questions about the recall should contact the company's vice president, Rick Martins, at (408) 293-5437.

Consumers with food safety questions can "Ask Karen," the FSIS virtual representative available 24 hours a day at AskKaren.gov. The toll-free USDA Meat and Poultry Hotline 1-888-MPHotline (1-888-674-6854) is available in English and Spanish and can be reached from l0 a.m. to 4 p.m. (Eastern Time) Monday through Friday. Recorded food safety messages are available 24 hours a day.

Source:
(Page 3 of 16)   « Prev  1  2  
3
  4  5  Next »
No blogs found.